Show
Sort by
-
- Journal Article
- A1
- open access
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023
-
- Miscellaneous
- open access
Editorial : targeting indoleamine 2,3-dioxygenases and tryptophan dioxygenase for cancer immunotherapy
-
- Journal Article
- A1
- open access
Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures
-
- Journal Article
- A1
- open access
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial
-
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma
-
- Journal Article
- A1
- open access
Immune checkpoint blockade for organ transplant patients with advanced cancer : how far can we go?
-
Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma
-
- Journal Article
- A1
- open access
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
-
Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma
-
- Journal Article
- A1
- open access
Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports